The emerging role of glutathione in alzheimer's disease

Journal of Alzheimer's Disease

Volumn 40, Issue 3, 2014, Pages 519-529

  Saharan, Sumiti ^a   Mandal, Pravat K ^a,b  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; amyloid peptide; biomarker; glutathione; oxidative stress

Indexed keywords

APOLIPOPROTEIN E; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; REACTIVE OXYGEN METABOLITE;

ALLELE; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANTIOXIDANT ACTIVITY; CEREBROSPINAL FLUID ANALYSIS; FRONTAL CORTEX; GLUTATHIONE METABOLISM; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; MINI MENTAL STATE EXAMINATION; NONHUMAN; OXIDATION REDUCTION STATE; PARIETAL CORTEX; PARIETAL LOBE; PENTOSE PHOSPHATE CYCLE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; ANIMAL; BRAIN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; BRAIN; GLUTATHIONE; HUMANS; OXIDATIVE STRESS;

EID: 84901911564     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132483     Document Type: Review

References (114)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191. (Pubitemid 46825511)
2. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA (2006) Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65, 631-641. (Pubitemid 44297254)
3. Lovell MA, Markesbery WR (2007) Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 85, 3036-3040. (Pubitemid 350057358)
4. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23, 134-147. (Pubitemid 27217017)
5. Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: A possibility for prevention. Neuropharmacology 59, 290-294.
6. Sultana R, Butterfield DA (2010) Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 19, 341-353.
7. Pamplona R, Dalfo E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, Portero-OtinM(2005) Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J Biol Chem 280, 21522-21530. (Pubitemid 40805718)
8. Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36, 747-751. (Pubitemid 24337634)
9. Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69, 155-167.
10. Perri R, Carlesimo GA, Serra L, Caltagirone C (2005) Characterization of memory profile in subjects with amnestic mild cognitive impairment. J Clin Exp Neuropsychol 27, 1033-1055. (Pubitemid 41527535)
11. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
12. Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease. Neurobiol Dis 22, 223-232.
13. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152-1156.
14. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA (2008) Redox proteomic identification of 4-hydroxy-2- nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 30, 107-120.
15. Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD (2005) Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 58, 730- 735. (Pubitemid 41552548)
16. Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 27, 1094-1099. (Pubitemid 43850642)
17. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65, 2146-2156.
18. Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M, Fenoglio C, Venturelli E, Baron P, Bresolin N, Scarpini E (2006) Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 27, 262-269. (Pubitemid 43038550)
19. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C (2010) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469, 6-10.
20. Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans: The role of glutathione in oxidative stressmediated neuronal death. Brain Res Brain Res Rev 25, 335-358. (Pubitemid 28071452)
21. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390, 191- 214.
22. Hammond CL, Lee TK, Ballatori N (2001) Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 34, 946-954. (Pubitemid 32595199)
23. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62, 649-671. (Pubitemid 30407139)
24. Raps SP, Lai JC, Hertz L, Cooper AJ (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 493, 398-401. (Pubitemid 19183160)
25. Jain A, Martensson J, Stole E, Auld PA, Meister A (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci U S A 88, 1913-1917. (Pubitemid 21916337)
26. Wullner U, Loschmann PA, Schulz JB, Schmid A, Dringen R, Eblen F, Turski L, Klockgether T (1996) Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. Neuroreport 7, 921-923. (Pubitemid 26167978)
27. Garcia JC, Remires D, Leiva A, Gonzalez R (2000) Depletion of brain glutathione potentiates the effect of 6- hydroxydopamine in a rat model of Parkinson's disease. J Mol Neurosci 14, 147-153. (Pubitemid 30660804)
28. Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384, 505-516. (Pubitemid 36609167)
29. Mytilineou C, Kramer BC, Yabut JA (2002) Glutathione depletion and oxidative stress. Parkinsonism Relat Disord 8, 385-387. (Pubitemid 36151653)
30. Wang X, Michaelis EK (2010) Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2, 12.
31. Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267, 4904-4911. (Pubitemid 30641286)
32. Pocernich CB, Butterfield DA (2011) Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim Biophys Acta 1822, 625-630.
33. Ghosh D, LeVault KR, Barnett AJ, Brewer GJ (2012) A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons. J Neurosci 32, 5821-5832.
34. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR (2008) Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 44, 2051-2057.
35. Zhang C, Rodriguez C, Spaulding J, Aw TY, Feng J (2012) Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease. J Alzheimers Dis 28, 655-666.
36. Ramassamy C, Averill D, Beffert U, Theroux L, Lussier- Cacan S, Cohn JS, Christen Y, Schoofs A, Davignon J, Poirier J (2000) Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 7, 23-37. (Pubitemid 30141817)
37. Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, Marsden CD, Schapira AH (1998) Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 158, 24-29. (Pubitemid 28277530)
38. Venkateshappa C, Harish G, MahadevanA, Srinivas Bharath MM, Shankar SK (2012) Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: Implications for neurodegeneration in Alzheimer's disease. Neurochem Res 37, 1601-1614.
39. Balazs L, LeonM(1994) Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem Res 19, 1131-1137. (Pubitemid 24284787)
40. Perry TL, YongVW, Bergeron C, Hansen S, Jones K (1987) Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Ann Neurol 21, 331-336. (Pubitemid 17053268)
41. Adams JD, Jr., Klaidman LK, Odunze IN, Shen HC, Miller CA (1991) Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin, E. Mol Chem Neuropathol 14, 213-226.
42. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak- Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
43. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90, 9649-9653. (Pubitemid 23315843)
44. White AR, Bush AI, Beyreuther K, Masters CL, Cappai R (1999) Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione. J Neurochem 72, 2092-2098. (Pubitemid 29186015)
45. Cardoso SM, Oliveira CR (2003) Glutathione cycle impairment mediates A beta-induced cell toxicity. Free Radic Res 37, 241-250. (Pubitemid 36181880)
46. Akterin S, Cowburn RF, Miranda-Vizuete A, Jimenez A, Bogdanovic N, Winblad B, Cedazo-Minguez A (2006) Involvement of glutaredoxin-1 and thioredoxin-1 in betaamyloid toxicity and Alzheimer's disease. Cell Death Differ 13, 1454-1465. (Pubitemid 44210349)
47. Abramov AY, Canevari L, Duchen MR (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23, 5088-5095. (Pubitemid 36793236)
48. Casley CS, Land JM, Sharpe MA, Clark JB, Duchen MR, Canevari L (2002) Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis 10, 258-267. (Pubitemid 35217579)
49. Lovell MA, Xie C, Markesbery WR (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566. (Pubitemid 28565232)
50. Sultana R, Piroddi M, Galli F, Butterfield DA (2008) Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem Res 33, 2540-2546.
51. Li YJ, Oliveira SA, Xu PT, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA (2003) Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12, 3259-3267. (Pubitemid 37541071)
52. Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin- Taner N (2012) Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: An association study with mechanistic implications. Mol Neurodegener 7, 13.
53. AksenovMY, Tucker HM, Nair P, AksenovaMV, Butterfield DA, Estus S, Markesbery WR (1998) The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J Mol Neurosci 11, 151-164. (Pubitemid 29140165)
54. Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, ShawCE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P,Ward M, Lovestone S (2006) Proteomebased plasma biomarkers for Alzheimer's disease. Brain 129, 3042-3050. (Pubitemid 44684524)
55. Bermejo P, Martin-Aragon S, Benedi J, Susin C, Felici E, Gil P, Ribera JM, Villar AM (2008) Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment. Free Radic Res 42, 162-170. (Pubitemid 351298365)
56. Puertas MC, Martinez-Martos JM, Cobo MP, Carrera MP, Mayas MD, Ramirez-Exposito MJ (2012) Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia. Exp Gerontol 47, 625-630.
57. Cristalli DO, Arnal N, Marra FA, de Alaniz MJ, Marra CA (2011) Peripheral markers in neurodegenerative patients and their first-degree relatives. J Neurol Sci 314, 48-56.
58. Liu H, Harrell LE, Shenvi S, Hagen T, Liu RM (2005) Gender differences in glutathione metabolism in Alzheimer's disease. J Neurosci Res 79, 861-867. (Pubitemid 40476510)
59. Baldeiras I, Santana I, Proenca MT, Garrucho MH, Pascoal R, Rodrigues A, Duro D, OliveiraCR(2010) Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment. J Alzheimers Dis 21, 1165-1177.
60. McCaddon A, Hudson P, Hill D, Barber J, Lloyd A, Davies G, Regland B (2003) Alzheimer's disease and total plasma aminothiols. Biol Psychiatry 53, 254-260. (Pubitemid 36135937)
61. Lloret A, Badia MC, Mora NJ, Pallardo FV, Alonso MD, Vina J (2009) Vitamin E paradox in Alzheimer's disease: It does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis 17, 143-149.
62. Trabesinger AH, Weber OM, Duc CO, Boesiger P (1999) Detection of glutathione in the human brain in vivo by means of double quantum coherence filtering.Magn Reson Med 42, 283-289. (Pubitemid 29364707)
63. Terpstra M, Henry PG, Gruetter R (2003) Measurement of reduced glutathione (GSH) in human brain using LCmodel analysis of difference-edited spectra. Magn Reson Med 50, 19-23. (Pubitemid 36841855)
64. Matsuzawa D, Hashimoto K (2011) Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. Antioxid Redox Signal 15, 2057-2065.
65. Mandal PK (2007) Magnetic resonance spectroscopy (MRS) and its application in Alzheimer's disease. Concept Magn Reson A 30A, 40-64.
66. Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG (2004) Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res 1012, 60-65. (Pubitemid 38648899)
67. Labak M, Foniok T, Kirk D, Rushforth D, Tomanek B, Jasinski A, Grieb P (2010) Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: A model of sporadic Alzheimer's disease. Acta Neurochir Suppl 106, 177-181.
68. Mandal PK, Tripathi M, Sugunan S (2012) Brain oxidative stress: Detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy. Biochem Biophys Res Commun 417, 43-48.
69. Duffy SL, Lagopoulos J, Hickie IB, Diamond K, Graeber MB, Lewis SJ, Naismith SL (2014) Glutathione relates to neuropsychological functioning in mild cognitive impairment. Alzheimers Dement 10, 67-75.
70. Palmer AM (1999) The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J Neural Transm 106, 317-328. (Pubitemid 29196935)
71. Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
72. Jack CR, Jr., Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
73. Laakso MP, Frisoni GB, Kononen M, Mikkonen M, Beltramello A, Geroldi C, Bianchetti A, Trabucchi M, Soininen H, Aronen HJ (2000) Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: A morphometric MRI study. Biol. Psychiatry 47, 1056-1063. (Pubitemid 30336214)
74. Mueller SG, Dickerson BC (2008) Atrophy accelerates with conversion from mild cognitive impairment to Alzheimer disease. Neurology 70, 1728-1729. (Pubitemid 351653948)
75. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM (2006) Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63, 693-699.
76. Apostolova LG, Green AE, Babakchanian S, Hwang KS, Chou YY, Toga AW, Thompson PM (2012) Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease. Alzheimer Dis Assoc Disord 26, 17-27.
77. Castellani RJ, Lee HG, Perry G, Smith MA (2006) Antioxidant protection and neurodegenerative disease: The role of amyloid-beta and tau. Am J Alzheimers Dis Other Demen 21, 126-130.
78. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H,Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-767. (Pubitemid 32678256)
79. Perry G, Smith MA (1998) Is oxidative damage central to the pathogenesis of Alzheimer disease? Acta Neurol Belg 98, 175-179. (Pubitemid 128522756)
80. Cai Z, Zhao B, Ratka A (2011) Oxidative stress and betaamyloid protein in Alzheimer's disease. Neuromolecular Med 13, 223-250.
81. Mandal PK (2012) In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites. Eur J Radiol 81, e653-e664.
82. Mandal PK, Akolkar H, TripathiM(2012) Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis 31(Suppl 3), S75-S86.
83. Mueller SG, Trabesinger AH, Boesiger P,WieserHG(1999) Glutathione levels in the brain of epileptic patients measured by proton-magnetic resonance spectroscopy. Epilepsia 40, 14-14.
84. Mueller SG, Trabesinger AH, Boesiger P,WieserHG(2001) Brain glutathione levels in patients with epilepsy measured by in vivo (1)H-MRS. Neurology 57, 1422-1427. (Pubitemid 32995723)
85. Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, Takanashi J, Matsuda T, Shimizu E, Ikehira H, Iyo M, & Hashimoto K (2008) Negative correlation between brain glutathione level and negative symptoms in schizophrenia: A 3T 1H-MRS study. PLoS One 3, e1944.
86. Wood SJ, Berger GE,Wellard RM, Proffitt TM,McConchie M, Berk M, McGorry PD, Pantelis C (2009) Medial temporal lobe glutathione concentration in first episode psychosis: A 1H-MRS investigation. Neurobiol Dis 33, 354-357.
87. Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, Cuenod M (2000) Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12, 3721-3728.
88. Choi IY, Lee SP, Denney DR, Lynch SG (2011) Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult Scler 17, 289-296.
89. Srinivasan R, Ratiney H, Hammond-Rosenbluth KE, Pelletier D, Nelson SJ (2010) MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. Magn Reson Imaging 28, 163-170.
90. Lagopoulos J, Hermens DF, Tobias-Webb J, Duffy S, Naismith SL, White D, Scott E, Hickie IB (2013) In vivo glutathione levels in young persons with bipolar disorder: A magnetic resonance spectroscopy study. J Psychiatr Res 47, 412-417.
91. Hermens DF, Lagopoulos J, Naismith SL, Tobias-Webb J, Hickie IB (2012) Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders. Transl Psychiatry 2, e110.
92. Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, Medow MS, Natelson BH, Stewart JM, Mathew SJ (2012) Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed 25, 1073-1087.
93. Swomley AM, Forster S, Keeney JT, Triplett J, Zhang Z, Sultana R, Butterfield DA (2013) Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies. Biochim Biophys Acta. doi: 10.1016/j.bbadis.2013. 09.015
94. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
95. Butterfield DA, Swomley AM, Sultana R (2013) Amyloid beta-peptide (1-42)-induced oxidative stress in Alzheimer disease: Importance in disease pathogenesis and progression. Antioxid Redox Signal 19, 823-835.
96. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc Natl Acad Sci U S A 91, 3270-3274.
97. Varadarajan S, Yatin S, Aksenova M, Butterfield DA (2000) Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130, 184-208.
98. Yatin SM, Yatin M, Aulick T, Ain KB, Butterfield DA (1999) Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: Protective effect of vitamin E. Neurosci Lett 263, 17-20. (Pubitemid 29138952)
99. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, Huang X, Farrag YW, Perry G, Bush AI (2000) Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 275, 19439- 19442. (Pubitemid 30441532)
100. Smith MA, Casadesus G, Joseph JA, Perry G (2002) Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 33, 1194- 1199. (Pubitemid 35246587)
101. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41, 17-24. (Pubitemid 27057088)
102. Tamagno E, Guglielmotto M, Monteleone D, Tabaton M (2012) Amyloid-beta production: Major link between oxidative stress and BACE1. Neurotox Res 22, 208-219.
103. Tayler H, Fraser T, Miners JS, Kehoe PG, Love S (2010) Oxidative balance in Alzheimer's disease: Relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-beta. J Alzheimers Dis 22, 1363- 1373.
104. Yan SD,Yan SF, Chen X, Fu J, Chen M,Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med 1, 693-699.
105. Sultana R, Butterfield DA (2013) Oxidative modification of brain proteins in Alzheimer's disease: Perspective on future studies based on results of redox proteomics studies. J Alzheimers Dis 33(Suppl 1), S243-S251.
106. Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, Wulf G, Lim J, Li SH, Li X, Xia W, Nicholson LK, Lu KP (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528-534.
107. Butterfield DA, Abdul HM, Opii W, Newman SF, Joshi G, Ansari MA, Sultana R (2006) Pin1 in Alzheimer's disease. J Neurochem 98, 1697-1706. (Pubitemid 44298238)
108. Holzer M, Gartner U, Stobe A, Hartig W, Gruschka H, Bruckner MK, Arendt T (2002) Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol 104, 471-481. (Pubitemid 36075415)
109. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68, 255-264. (Pubitemid 26427315)
110. Boyd-Kimball D, Sultana R, Abdul HM, Butterfield DA (2005) Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. J Neurosci Res 79, 700-706. (Pubitemid 40476449)
111. Paik SR, Lee D, Cho HJ, Lee EN, Chang CS (2003) Oxidized glutathione stimulated the amyloid formation of alpha-synuclein. FEBS Lett 537, 63-67. (Pubitemid 36246677)
112. Wang SS, Chou SW, Liu KN,Wu CH (2009) Effects of glutathione on amyloid fibrillation of hen egg-white lysozyme. Int J Biol Macromol 45, 321-329.
113. Woltjer RL, Nghiem W, Maezawa I, Milatovic D, Vaisar T, Montine KS, Montine TJ (2005) Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J Neurochem 93, 1047-1056. (Pubitemid 40695764)
114. Cacciatore I, Baldassarre L, Fornasari E, Mollica A, Pinnen F (2012) Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. Oxid Med Cell Longev 2012, 240146.